Type 1 vs type 2 myocardial infarction in tabular form
| Feature | Type 1 MI | Type 2 MI |
|---|---|---|
| Alternate Name | Spontaneous MI | Ischemic Imbalance MI |
| Core Mechanism | Primary coronary event - atherosclerotic plaque rupture, erosion, fissuring, or dissection causing intraluminal thrombus | Supply-demand mismatch NOT directly caused by acute coronary thrombosis |
| Pathophysiology | Thrombus occludes the coronary lumen - decreasing myocardial blood flow and causing myocyte necrosis | Conditions that either reduce oxygen supply or increase oxygen demand beyond supply |
| Common Causes | - Plaque rupture/erosion - Intraluminal thrombosis - Distal platelet emboli | - Coronary artery spasm - Coronary embolism - Tachyarrhythmia / bradyarrhythmia - Anemia - Respiratory failure - Hypotension / hypertension - Coronary endothelial dysfunction - Spontaneous coronary artery dissection (SCAD) |
| Underlying Coronary Disease | Usually obstructive CAD; occasionally nonobstructive or no CAD (MINOCA) | May or may not have underlying atherosclerotic obstructive CAD |
| Troponin Pattern | Acute rise and fall (reflects active necrosis from plaque event) | Acute rise and fall, but attributed to supply-demand mismatch rather than plaque rupture |
| ECG Changes | STEMI or NSTEMI pattern (ST elevation, ST depression, T-wave changes, new LBBB) | Variable - may mirror STEMI/NSTEMI pattern; depends on the triggering cause |
| Coronary Angiography | Typically shows culprit lesion with thrombus, plaque rupture, or occlusion | May show obstructive CAD, spasm, dissection, embolism, or normal coronaries |
| Management | Invasive strategy - urgent PCI is primary treatment (STEMI); medical stabilization for MINOCA | Treat the underlying trigger (control arrhythmia, correct anemia, treat sepsis/respiratory failure, relieve vasospasm); PCI usually NOT the primary intervention |
| Prognosis Consideration | Prognosis driven by infarct size and LV function; revascularization directly improves outcome | Prognosis depends heavily on the underlying precipitant; mortality tied to the comorbid condition |
| Typical Patient | History of atherosclerosis risk factors (hypertension, hyperlipidemia, smoking, diabetes, family history) | Often critically ill or in the perioperative setting; young women with SCAD; patients with vasospastic disease |
| Biomarker Threshold (diagnosis) | Rise/fall of cardiac troponin with at least one value >99th percentile URL | Same biomarker criterion applies, but the cause determines type 2 classification |
Causes of eye twitching including nutritional causes
causes of eye twitching nutritional deficiencies magnesium vitamin
| Cause | Mechanism |
|---|---|
| Fatigue / lack of sleep | Reduces motor neuron threshold; increases excitability |
| Excess caffeine | Stimulates the nervous system; lowers seizure threshold in motor neurons |
| Stress and anxiety | Neurochemical dysregulation causes heightened neuromuscular irritability |
| Alcohol | Stimulating and depressant effects on neural circuits; disrupts muscle control |
| Eye strain / digital eye strain | Prolonged visual effort fatigues the orbicularis oculi |
| Dehydration | Reduces electrolyte balance; affects nerve conduction |
| Cause | Notes |
|---|---|
| Dry eye syndrome | Corneal surface irritation reflexively triggers orbicularis contraction |
| Corneal / conjunctival irritation | Foreign body, abrasion, keratitis, blepharitis |
| Ocular inflammation | Uveitis, episcleritis |
| Photosensitivity | Seen in albinism, congenital glaucoma - reflex blepharospasm |
| Refractive error / poorly fitting glasses | Sustained squinting fatigues the eyelid muscles |
| Deficiency | Mechanism |
|---|---|
| Magnesium deficiency | Magnesium regulates neuromuscular transmission; low levels increase excitability of motor neurons - a well-recognized trigger for muscle fasciculations including eyelid twitching |
| Vitamin B12 deficiency | Essential for myelin sheath integrity and nerve conduction; deficiency disrupts normal motor nerve function and can cause involuntary movements |
| Vitamin D deficiency | Vitamin D is required for calcium absorption and muscle function; low levels indirectly impair calcium-dependent muscle relaxation |
| Calcium (hypocalcemia) | Calcium is integral to muscle contraction-relaxation coupling; low calcium raises neuromuscular excitability (Chvostek sign is the facial equivalent) |
| Potassium imbalance | Hypo- or hyperkalemia can alter resting membrane potential of muscle fibers, causing spontaneous discharges |
| Electrolyte imbalance (general) | Seen with dehydration, excessive sweating, poor diet - affects Na/K/Ca/Mg balance governing muscle membrane stability |
Key point: Of all nutritional causes, magnesium deficiency and vitamin B12 deficiency are the most clinically recognized triggers. A balanced diet or targeted supplementation typically resolves nutritional eye twitching.
| Condition | Features |
|---|---|
| Benign essential blepharospasm (BEB) | Bilateral, progressive, focal dystonia - forceful involuntary eyelid closure; no other neurological cause identified |
| Meige syndrome | Blepharospasm + oromandibular dystonia (segmental dystonia) |
| Hemifacial spasm | Unilateral synchronous contraction of all facial muscles; caused by vascular compression of CN VII at the root entry zone |
| Facial myokymia | Rippling contractions of facial muscles; associated with multiple sclerosis, brainstem gliomas, Guillain-Barre syndrome, syringobulbia |
| Parkinsonism | Reflex blepharospasm is seen; all types of blepharospasm worsen with lid manipulation |
| Myotonic dystrophy | Myotonia of lid closure - delayed relaxation after contraction |
| Tourette syndrome | Motor tics including eye blinking/twitching |
| Tic douloureux (trigeminal neuralgia) | Facial twitching associated with paroxysmal pain |
| Brainstem lesions | Tumors, demyelination causing facial myokymia |
| Cause | Notes |
|---|---|
| Stimulant medications | Amphetamines, decongestants, certain ADHD medications |
| Lithium intoxication | Can cause blepharospasm and apraxia of eyelid opening |
| Caffeine-containing medications | Including some analgesics |
| Withdrawal states | From CNS depressants (alcohol, benzodiazepines) |
| Condition | Notes |
|---|---|
| Hypothyroidism | Can cause myotonia of lid closure |
| Hyperkalemic / hypokalemic familial periodic paralysis | Associated with myotonia of lid closure |
| Anemia | Reduces oxygen delivery; combined with electrolyte shifts can precipitate muscle irritability |
| Multiple sclerosis | Via facial myokymia from brainstem demyelination |
| Paraneoplastic syndromes | Lung cancer, thymoma - anti-voltage-gated potassium channel antibodies cause myokymia |